Europe Revenue Cycle Management Market - Industry Trends and Forecast to 2029

TABLE OF CONTENT

TABLE OF CONTENTS
1 INTRODUCTION 18
1.1 OBJECTIVES OF THE STUDY 18
1.2 MARKET DEFINITION 18
1.3 OVERVIEW OF EUROPE REVENUE CYCLE MANAGEMENT MARKET 18
1.4 CURRENCY AND PRICING 20
1.5 LIMITATIONS 20
1.6 MARKETS COVERED 21
2 MARKET SEGMENTATION 24
2.1 MARKETS COVERED 24
2.2 GEOGRAPHICAL SCOPE 25
2.3 YEARS CONSIDERED FOR THE STUDY 25
2.4 DBMR TRIPOD DATA VALIDATION MODEL 26
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 29
2.6 DBMR MARKET POSITION GRID 30
2.7 VENDOR SHARE ANALYSIS 32
2.8 MULTIVARIATE MODELING 33
2.9 PRODUCT & SERVICES TIMELINE CURVE 33
2.10 MARKET END USERCOVERAGE GRID 34
2.11 SECONDARY SOURCES 35
2.12 ASSUMPTIONS 35
3 EXECUTIVE SUMMARY 36
4 PREMIUM INSIGHTS 39
4.1 PORTERS FIVE FORCES MODEL 40
4.2 PESTEL ANALYSIS 41
5 MARKET OVERVIEW 42
5.1 DRIVERS 44
5.1.1 INCREASING NEED TO SIMPLIFY CLAIM PROCESSING AND SUBMISSION 44
5.1.2 SURGING PREFERENCE TOWARD AUTOMATED OPERATIONAL PROCEDURES 44
5.1.3 GROWING FOCUS OF HEALTHCARE PROFESSIONALS TOWARD PATIENT CARE 45
5.1.4 RAPID DEMAND OF HOSPITALS FOR EFFICIENT BILLING PROCESS MANAGEMENT 46
5.1.5 PROVIDING CRITICAL INSIGHTS FOR REPORTING, BENCHMARKING, AND COMPLIANCE 46

5.2 RESTRAINTS 47
5.2.1 HIGH COST OF DEPLOYMENT AND MAINTAINING OF REVENUE CYCLE MANAGEMENT SOFTWARE 47
5.2.2 DEPENDENCY ON CONVENTIONAL HEALTHCARE INFORMATION TECHNOLOGY BY CLINICIANS 47
5.3 OPPORTUNITIES 48
5.3.1 DIGITAL TRANSFORMATION APPLICATIONS OF CLOUD-BASED SOLUTIONS IN RCM HEALTHCARE 48
5.3.2 NEED FOR SELF-CARE AND MOBILE-BASED SOLUTIONS 48
5.3.3 CREATING PROACTIVE REVENUE CYCLE WITH AI, RPA, AND CHATBOTS 48
5.3.4 INCREASE IN PATIENT VOLUME OF BOTH INSURED AND NON-INSURED PATIENTS WITH IMPACT OF PANDEMIC 49
5.4 CHALLENGES 49
5.4.1 DATA SECURITY CONCERNS 49
5.4.2 MEETING COMPLIANCE STANDARDS AND SAFEGUARDING PRIVACY AND CONFIDENTIALITY OF HEALTH INFORMATION 50
6 IMPACT OF COVID-19 ON EUROPE REVENUE CYCLE MANAGEMENT MARKET 51
6.1 ANALYSIS ON IMPACT OF COVID-19 ON THE MARKET 51
6.2 IMPACT ON DEMAND 51
6.3 IMPACT ON SUPPLY CHAIN 52
6.4 PRICE IMPACT 52
6.5 LONG TERM STRATEGY OR STEPS TAKEN BY MANUFACTURERS 52
6.6 CONCLUSION 53
7 EUROPE REVENUE CYCLE MANAGEMENT MARKET, BY PRODUCT & SERVICES 54
7.1 OVERVIEW 55
7.2 SOLUTIONS 56
7.2.1 PATIENT ACCESS SOLUTIONS 56
7.2.1.1 PRE-CERTIFICATION & AUTHORIZATION SOLUTIONS 57
7.2.1.2 ELIGIBILITY VERIFICATION SOLUTIONS 57
7.2.1.3 OTHER PATIENT ACCESS SOLUTIONS 57
7.2.2 MID-REVENUE CYCLE SOLUTIONS 57
7.2.2.1 CLINICAL CODING SOLUTIONS 58
7.2.2.2 CLINICAL DOCUMENTATION IMPROVEMENT SOLUTIONS 58
7.2.2.3 OTHER MID-REVENUE CYCLE SOLUTIONS 58
7.2.3 BACK-END REVENUE CYCLE SOLUTIONS 58
7.2.3.1 CLAIMS PROCESSING SOLUTIONS 58
7.2.3.2 DENIAL MANAGEMENT SOLUTIONS 58
7.2.3.3 OTHER BACK-END REVENUE CYCLE SOLUTIONS 58

7.3 OUTSOURCING SERVICES 59
7.3.1 PATIENT ACCESS OUTSOURCING SERVICES 59
7.3.2 MID-REVENUE CYCLE OUTSOURCING SERVICES 59
7.3.3 BACK-END REVENUE CYCLE OUTSOURCING SERVICES 59
8 EUROPE REVENUE CYCLE MANAGEMENT MARKET, BY DELIVERY MODE 60
8.1 OVERVIEW 61
8.2 ON-PREMISE SOLUTIONS 62
8.3 CLOUD-BASED SOLUTIONS 62
9 EUROPE REVENUE CYCLE MANAGEMENT MARKET, BY TYPE 63
9.1 OVERVIEW 64
9.2 INTEGRATED 65
9.3 STANDALONE 65
10 EUROPE REVENUE CYCLE MANAGEMENT MARKET, BY FUNCTION 66
10.1 OVERVIEW 67
10.2 CLAIMS & DENIAL MANAGEMENT 68
10.3 MEDICAL CODING & BILLING 68
10.4 ELECTRONIC HEALTH RECORD (EHR) 68
10.5 CLINICAL DOCUMENTATION IMPROVEMENT (CDI) 69
10.6 INSURANCE 69
10.7 OTHER FUNCTIONS 69
11 EUROPE REVENUE CYCLE MANAGEMENT MARKET, BY END USER 70
11.1 OVERVIEW 71
11.2 HEALTHCARE PROVIDERS 72
11.2.1 INPATIENT FACILITIES 73
11.2.1.1 HOSPITALS 73
11.2.1.2 CLINICS 73
11.2.1.3 OTHERS 73
11.2.2 OUTPATIENT FACILITIES 73
11.2.2.1 HOSPITAL OUTPATIENT FACILITIES 74
11.2.2.2 AMBULATORY SURGICAL CENTERS (ASCS) 74
11.2.2.3 DIAGNOSTIC & IMAGING CENTERS 74
11.2.2.4 PHYSICIANS PRACTICES 74
11.2.2.5 OTHER OUTPATIENT FACILITIES 74
11.3 HEALTHCARE PLAYERS 75

12 EUROPE REVENUE CYCLE MANAGEMENT MARKET, BY COUNTRY 76
12.1 EUROPE 76
12.1.1 GERMANY 81
12.1.2 FRANCE 85
12.1.3 U.K. 89
12.1.4 SPAIN 93
12.1.5 ITALY 97
12.1.6 RUSSIA 101
12.1.7 SWITZERLAND 105
12.1.8 NETHERLANDS 109
12.1.9 TURKEY 113
12.1.10 BELGIUM 117
12.1.11 REST OF EUROPE 121
13 EUROPE REVENUE CYCLE MANAGEMENT MARKET: COMPANY LANDSCAPE 122
13.1 COMPANY SHARE ANALYSIS: EUROPE 122
14 COMPANY PROFILE 123
14.1 MCKESSON CORPORATION 123
14.1.1 COMPANY SNAPSHOT 123
14.1.2 REVENUE ANALYSIS 123
14.1.3 PRODUCT PORTFOLIO 124
14.1.4 RECENT DEVELOPMENTS 124
14.1.5 SWOT ANLYSIS 125
14.2 QUEST DIAGNOSTICS, INC 126
14.2.1 COMPANY SNAPSHOT 126
14.2.2 REVENUE ANALYSIS 126
14.2.3 PRODUCT PORTFOLIO 127
14.2.4 RECENT DEVELOPMENT 127
14.2.5 SWOT ANALYSIS 127
14.3 3M 128
14.3.1 COMPANY SNAPSHOT 128
14.3.2 REVENUE ANALYSIS 128
14.3.3 PRODUCT PORTFOLIO 129
14.3.4 RECENT DEVELOPMENTS 129
14.3.5 SWOT ANALYSIS 130
14.4 OPTUM INC. 131
14.4.1 COMPANY SNAPSHOT 131
14.4.2 PRODUCT PORTFOLIO 131
14.4.3 RECENT DEVELOPMENTS 131
14.4.4 SWOT ANALYSIS 132
14.5 ACCENTURE 133
14.5.1 COMPANY SNAPSHOT 133
14.5.2 REVENUE ANALYSIS 133
14.5.3 PRODUCT PORTFOLIO 134
14.5.4 RECENT DEVELOPMENT 134
14.5.5 SWOT ANALYSIS 135
14.6 ADVANTEDGE HEALTHCARE SOLUTIONS 136
14.6.1 COMPANY SNAPSHOT 136
14.6.2 PRODUCT PORTFOLIO 136
14.6.3 RECENT DEVELOPMENT 137
14.7 AIMA BUSINESS AND MEDICAL SUPPORT LLC 138
14.7.1 COMPANY SNAPSHOT 138
14.7.2 SERVICE PORTFOLIO 138
14.7.3 RECENT DEVELOPMENT 138
14.8 ALLSCRIPTS HEALTHCARE, LLC 139
14.8.1 COMPANY SNAPSHOT 139
14.8.2 REVENUE ANALYSIS 139
14.8.3 SOLUTION PORTFOLIO 140
14.8.4 RECENT DEVELOPMENT 140
14.9 ALVAREZ & MARSAL HOLDINGS, LLC 141
14.9.1 COMPANY SNAPSHOT 141
14.9.2 PRODUCT PORTFOLIO 141
14.9.3 RECENT DEVELOPMENT 141
14.10 ATOS SE 142
14.10.1 COMPANY SNAPSHOT 142
14.10.2 REVENUE ANALYSIS 142
14.10.3 PRODUCT PORTFOLIO 143
14.10.4 RECENT DEVELOPMENT 143
14.11 BRIGHTREE LLC 144
14.11.1 COMPANY SNAPSHOT 144
14.11.2 PRODUCT PORTFOLIO 144
14.11.3 RECENT DEVELOPMENTS 145
14.12 CERNER CORPORATION 146
14.12.1 COMPANY SNAPSHOT 146
14.12.2 REVENUE ANALYSIS 146
14.12.3 PRODUCT PORTFOLIO 147
14.12.4 RECENT DEVELOPMENTS 147

14.13 CHETU INC 148
14.13.1 1.13.1 COMPANY SNAPSHOT 148
14.13.2 PRODUCT PORTFOLIO 148
14.13.3 RECENT DEVELOPMENTS 149
14.14 COGNIZANT 150
14.14.1 COMPANY SNAPSHOT 150
14.14.2 REVENUE ANALYSIS 150
14.14.3 SERVICE PORTFOLIO 151
14.14.4 RECENT DEVELOPMENT 151
14.15 CROWE LLP 152
14.15.1 COMPANY SNAPSHOT 152
14.15.2 PRODUCT PORTFOLIO 152
14.15.3 RECENT DEVELOPMENTS 152
14.16 ECLINICALWORKS 153
14.16.1 COMPANY SNAPSHOT 153
14.16.2 PRODUCT PORTFOLIO 153
14.16.3 RECENT DEVELOPMENT 153
14.17 EPIC SYSTEMS CORPORATION 154
14.17.1 COMPANY SNAPSHOT 154
14.17.2 PRODUCT PORTFOLIO 154
14.17.3 RECENT DEVELOPMENTS 155
14.18 EXPERIAN PLC 156
14.18.1 COMPANY SNAPSHOT 156
14.18.2 REVENUE ANALYSIS 157
14.18.3 PRODUCT PORTFOLIO 157
14.18.4 RECENT DEVELOPMENT 157
14.19 FLATWORLD SOLUTIONS PVT. LTD 158
14.19.1 COMPANY SNAPSHOT 158
14.19.2 PRODUCT PORTFOLIO 158
14.19.3 RECENT DEVELOPMENT 159
14.20 GENERAL ELECTRIC COMPANY 160
14.20.1 COMPANY SNAPSHOT 160
14.20.2 REVENUE ANALYSIS 160
14.20.3 BUSINESS PORTFOLIO 161
14.20.4 RECENT DEVELOPMENT 161
14.21 HINDUJA GLOBAL SOLUTIONS LTD. 162
14.21.1 COMPANY SNAPSHOT 162
14.21.2 REVENUE ANALYSIS 162
14.21.3 PRODUCT PORTFOLIO 163
14.21.4 RECENT DEVELOPMENT 164
14.22 HURON CONSULTING GROUP 165
14.22.1 1.22.1 COMPANY SNAPSHOT 165
14.22.2 REVENUE ANALYSIS 165
14.22.3 PRODUCT PORTFOLIO 166
14.22.4 RECENT DEVELOPMENT 166
14.23 IBM CORPORATION 167
14.23.1 COMPANY SNAPSHOT 167
14.23.2 REVENUE ANALYSIS 167
14.23.3 PRODUCT PORTFOLIO 168
14.23.4 RECENT DEVELOPMENT 168
14.24 NTT DATA, INC. 169
14.24.1 COMPANY SNAPSHOT 169
14.24.2 REVENUE ANALYSIS 169
14.24.3 PRODUCT PORTFOLIO 170
14.24.4 RECENT DEVELOPMENT 170
14.25 PROTIVITI INC. (A SUBSIDIARY OF ROBERT HALF INTERNATIONAL INC.) 171
14.25.1 COMPANY SNAPSHOT 171
14.25.2 REVENUE ANALYSIS 171
14.25.3 PRODUCT PORTFOLIO 172
14.25.4 RECENT DEVELOPMENT 172
14.26 WIPRO LIMITED 173
14.26.1 COMPANY SNAPSHOT 173
14.26.2 REVENUE ANALYSIS 173
14.26.3 PRODUCT PORTFOLIO 174
14.26.4 RECENT DEVELOPMENT 174
15 QUESTIONNAIRE 175
16 RELATED REPORTS 178